NDC 55111-119

Famotidine

Famotidine

Famotidine is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Dr.reddy's Laboratories Limited. The primary component is Famotidine.

Product ID55111-119_47fe9600-534c-3502-b5fe-872b675c050e
NDC55111-119
Product TypeHuman Prescription Drug
Proprietary NameFamotidine
Generic NameFamotidine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2001-04-16
Marketing CategoryANDA / ANDA
Application NumberANDA075718
Labeler NameDr.Reddy's Laboratories Limited
Substance NameFAMOTIDINE
Active Ingredient Strength20 mg/1
Pharm ClassesHistamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 55111-119-01

100 TABLET, FILM COATED in 1 BOTTLE (55111-119-01)
Marketing Start Date2001-04-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55111-119-01 [55111011901]

Famotidine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA075718
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-04-16

NDC 55111-119-10 [55111011910]

Famotidine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA075718
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-04-16

NDC 55111-119-30 [55111011930]

Famotidine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA075718
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-04-16

Drug Details

Active Ingredients

IngredientStrength
FAMOTIDINE20 mg/1

OpenFDA Data

SPL SET ID:06d286ce-14b3-4b66-8b42-ac4a10a0fc90
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310273
  • 284245
  • UPC Code
  • 0355111119302
  • Pharmacological Class

    • Histamine H2 Receptor Antagonists [MoA]
    • Histamine-2 Receptor Antagonist [EPC]
    • Histamine H2 Receptor Antagonists [MoA]
    • Histamine-2 Receptor Antagonist [EPC]

    Medicade Reported Pricing

    55111011910 FAMOTIDINE 20 MG TABLET

    Pricing Unit: EA | Drug Type:

    55111011901 FAMOTIDINE 20 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Famotidine" or generic name "Famotidine"

    NDCBrand NameGeneric Name
    0093-2748FamotidineFamotidine
    0172-5728FamotidineFamotidine
    0172-5729FamotidineFamotidine
    0338-5197FamotidineFamotidine
    0363-0036FamotidineFamotidine
    0363-1899FamotidineFamotidine
    68001-240FamotidineFamotidine
    68001-241FamotidineFamotidine
    68071-1879FamotidineFamotidine
    68071-3181FamotidineFamotidine
    68071-1941FamotidineFamotidine
    68071-3305FamotidineFamotidine
    68071-4197FamotidineFamotidine
    68071-3201FamotidineFamotidine
    68151-0184FamotidineFamotidine
    68151-0185FamotidineFamotidine
    68180-150FamotidineFamotidine
    68210-0007FAMOTIDINEFAMOTIDINE
    68382-444FamotidineFamotidine
    68645-140FamotidineFamotidine
    68645-141FamotidineFamotidine
    68788-6859FamotidineFamotidine
    68788-6399FamotidineFamotidine
    68788-9217FamotidineFamotidine
    68788-7191FamotidineFamotidine
    68788-9549FamotidineFamotidine
    68788-9220FamotidineFamotidine
    68788-9779FamotidineFamotidine
    70253-128FamotidineFamotidine
    70518-0460FamotidineFamotidine
    70518-0461FamotidineFamotidine
    70518-0163FamotidineFamotidine
    70518-1415FamotidineFamotidine
    70518-1341FamotidineFamotidine
    70518-1001FamotidineFamotidine
    70518-1089FamotidineFamotidine
    70518-1877FamotidineFamotidine
    71335-0409FamotidineFamotidine
    0615-4582FamotidineFamotidine
    71335-0370FamotidineFamotidine
    0615-4594FamotidineFamotidine
    72036-026FamotidineFamotidine
    0641-6023FamotidineFamotidine
    0641-6022FamotidineFamotidine
    0641-6021FamotidineFamotidine
    10544-481FamotidineFamotidine
    12634-967FamotidineFamotidine
    15127-370FamotidineFamotidine
    33261-185FamotidineFamotidine
    33261-562FamotidineFamotidine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.